Evaluating the Clinical Utility of the Glycemia Risk Index
Authors' conclusion
The GRI is perceived as a valuable complement to traditional CGM reports, particularly in facilitating quick clinical assessments and furthering diabetes care and education. While enthusiasm for broader integration is high, barriers such as lack of standardization, limited guideline adoption, and HCP training must be addressed to support its clinical uptake. Future work should assess the GRI's impact on clinical outcomes and explore implementation strategies.
Study context
- Population
- Diabetes Care and Education Specialists (DCESs) and other health care professionals
- Participants
- 28 participants
- Exposure
- Glycemia Risk Index (GRI) vs Ambulatory Glucose Profile (AGP)
- Outcome
- Perceptions of GRI usefulness and preferences
Methodological detailsvirtual educational session followed by online survey, thematic analysis of free-text responses
- Virtual educational session followed by online survey
- Thematic analysis of free-text responses
Main finding
As reported in the abstract
- Preferred both GRI and AGP for tracking individual progress over time
- 50%
- Preferred GRI alone
- 39%
- Preferred AGP alone
- 11%
- Willing to integrate GRI into clinical workflows
- 75%
- Rating of GRI advantages (5-point Likert), mean ± SD
- 4.57 ± 0.84
- Usefulness for primary care practitioners
- 4.5 ± 0.96
- Usefulness for diabetes specialists
- 4.18 ± 1.28
- Concerns about disadvantages
- 3.04 ± 1.20
Observational data: associations, not effects.
Original publication
Evaluating the Clinical Utility of the Glycemia Risk Index. J Diabetes Sci Technol. Published 14 October 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →